{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:31:03Z","timestamp":1782307863294,"version":"3.54.5"},"reference-count":89,"publisher":"Edizioni Minerva Medica","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Minerva Med"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.23736\/s0026-4806.20.07019-6","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T02:44:48Z","timestamp":1606790688000},"source":"Crossref","is-referenced-by-count":15,"title":["Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future"],"prefix":"10.23736","volume":"111","author":[{"given":"Michele","family":"Gottardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Sperotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ghelli Luserna Di Ror\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Padella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Cangini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B.","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cerchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17149","reference":[{"key":"10.23736\/S0026-4806.20.07019-6_ref001","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.5.1030.1030"},{"key":"10.23736\/S0026-4806.20.07019-6_ref002","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-325050"},{"key":"10.23736\/S0026-4806.20.07019-6_ref003","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.309"},{"key":"10.23736\/S0026-4806.20.07019-6_ref004","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-398370"},{"key":"10.23736\/S0026-4806.20.07019-6_ref005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-523548"},{"key":"10.23736\/S0026-4806.20.07019-6_ref006","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.043786"},{"key":"10.23736\/S0026-4806.20.07019-6_ref007","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.39"},{"key":"10.23736\/S0026-4806.20.07019-6_ref008","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.6846"},{"key":"10.23736\/S0026-4806.20.07019-6_ref009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-689976"},{"key":"10.23736\/S0026-4806.20.07019-6_ref010","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.147"},{"key":"10.23736\/S0026-4806.20.07019-6_ref011","doi-asserted-by":"publisher","DOI":"10.1021\/bc010021y"},{"key":"10.23736\/S0026-4806.20.07019-6_ref012","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.11.3678"},{"key":"10.23736\/S0026-4806.20.07019-6_ref013","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.13.3244"},{"key":"10.23736\/S0026-4806.20.07019-6_ref014","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21326"},{"key":"10.23736\/S0026-4806.20.07019-6_ref015","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-466706"},{"key":"10.23736\/S0026-4806.20.07019-6_ref016","first-page":"1490","article-title":"Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross PF","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.23736\/S0026-4806.20.07019-6_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.07.005"},{"key":"10.23736\/S0026-4806.20.07019-6_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2016.03.004"},{"key":"10.23736\/S0026-4806.20.07019-6_ref019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0255"},{"key":"10.23736\/S0026-4806.20.07019-6_ref020","unstructured":"Brifing Document FD. Oncologic Drugs Advisory Committee Meeting, BLA 761060, Mylotarg (gemtuzumab ozogamicin); 2017 [Internet]. Available from: httpps:\/\/www.fda.gov7downloads\/AdvisoryCommittees\/Committeess-MeetingMaterials\/Drugs\/Oncologic-DrugsAdvisory-Committee\/UCM566013.pdf. [cited 2020, Oct 2 ]."},{"key":"10.23736\/S0026-4806.20.07019-6_ref021","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1687"},{"key":"10.23736\/S0026-4806.20.07019-6_ref022","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403350"},{"key":"10.23736\/S0026-4806.20.07019-6_ref023","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.3197"},{"key":"10.23736\/S0026-4806.20.07019-6_ref024","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403598"},{"key":"10.23736\/S0026-4806.20.07019-6_ref025","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404434"},{"key":"10.23736\/S0026-4806.20.07019-6_ref026","unstructured":"Wyeth Pharmaceuticals. Mylotarg (gemtuzumab ozogamicin) [prescribing information] Philadelphia, PA: Wyeth Pharmaceuticals; 2017."},{"key":"10.23736\/S0026-4806.20.07019-6_ref027","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3179"},{"key":"10.23736\/S0026-4806.20.07019-6_ref028","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.4310"},{"key":"10.23736\/S0026-4806.20.07019-6_ref029","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.2964"},{"key":"10.23736\/S0026-4806.20.07019-6_ref030","doi-asserted-by":"crossref","unstructured":"Delaunay J, Recher C, Pigneux A. Addition of gemtuzumab ozogamicin to chemotherapy improves event-free survival but not overall survival of AML patients with intermediate cytogenetics not eligible for allogeneic transplantation: results of the GOELAMS AML 2006 IR study. Blood (ASH annual meeting abstract) 2001;118:abstr79","DOI":"10.1182\/blood.V118.21.79.79"},{"key":"10.23736\/S0026-4806.20.07019-6_ref031","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70281-5"},{"key":"10.23736\/S0026-4806.20.07019-6_ref032","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.0060"},{"key":"10.23736\/S0026-4806.20.07019-6_ref033","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-100669"},{"key":"10.23736\/S0026-4806.20.07019-6_ref034","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-747170"},{"key":"10.23736\/S0026-4806.20.07019-6_ref035","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300874"},{"key":"10.23736\/S0026-4806.20.07019-6_ref036","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.1982"},{"key":"10.23736\/S0026-4806.20.07019-6_ref037","first-page":"1108","article-title":"The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study","volume":"8","author":"Paietta E","year":"1994","journal-title":"Leukemia"},{"key":"10.23736\/S0026-4806.20.07019-6_ref038","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001278"},{"key":"10.23736\/S0026-4806.20.07019-6_ref039","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276196"},{"key":"10.23736\/S0026-4806.20.07019-6_ref040","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-266007"},{"key":"10.23736\/S0026-4806.20.07019-6_ref041","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00193-X"},{"key":"10.23736\/S0026-4806.20.07019-6_ref042","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00115-5"},{"key":"10.23736\/S0026-4806.20.07019-6_ref043","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.127"},{"key":"10.23736\/S0026-4806.20.07019-6_ref044","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1550"},{"key":"10.23736\/S0026-4806.20.07019-6_ref045","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.187"},{"key":"10.23736\/S0026-4806.20.07019-6_ref046","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003471"},{"key":"10.23736\/S0026-4806.20.07019-6_ref047","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7625827"},{"key":"10.23736\/S0026-4806.20.07019-6_ref048","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.185"},{"key":"10.23736\/S0026-4806.20.07019-6_ref049","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt666"},{"key":"10.23736\/S0026-4806.20.07019-6_ref050","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00387"},{"key":"10.23736\/S0026-4806.20.07019-6_ref051","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.988"},{"key":"10.23736\/S0026-4806.20.07019-6_ref052","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-047399"},{"key":"10.23736\/S0026-4806.20.07019-6_ref053","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01172.x"},{"key":"10.23736\/S0026-4806.20.07019-6_ref054","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709059682"},{"key":"10.23736\/S0026-4806.20.07019-6_ref055","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0396"},{"key":"10.23736\/S0026-4806.20.07019-6_ref056","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401361"},{"key":"10.23736\/S0026-4806.20.07019-6_ref057","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.6.3604"},{"key":"10.23736\/S0026-4806.20.07019-6_ref058","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024265"},{"key":"10.23736\/S0026-4806.20.07019-6_ref059","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25057"},{"key":"10.23736\/S0026-4806.20.07019-6_ref060","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.01.019"},{"key":"10.23736\/S0026-4806.20.07019-6_ref061","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106421"},{"key":"10.23736\/S0026-4806.20.07019-6_ref062","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.11.007"},{"key":"10.23736\/S0026-4806.20.07019-6_ref063","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-506592"},{"key":"10.23736\/S0026-4806.20.07019-6_ref064","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904544"},{"key":"10.23736\/S0026-4806.20.07019-6_ref065","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-414425"},{"key":"10.23736\/S0026-4806.20.07019-6_ref066","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.07.026"},{"key":"10.23736\/S0026-4806.20.07019-6_ref067","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-309229"},{"key":"10.23736\/S0026-4806.20.07019-6_ref068","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005998"},{"key":"10.23736\/S0026-4806.20.07019-6_ref069","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01406"},{"key":"10.23736\/S0026-4806.20.07019-6_ref070","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24000"},{"key":"10.23736\/S0026-4806.20.07019-6_ref071","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.9628"},{"key":"10.23736\/S0026-4806.20.07019-6_ref072","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.8121"},{"key":"10.23736\/S0026-4806.20.07019-6_ref073","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-503847"},{"key":"10.23736\/S0026-4806.20.07019-6_ref074","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.131946"},{"key":"10.23736\/S0026-4806.20.07019-6_ref075","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507471"},{"key":"10.23736\/S0026-4806.20.07019-6_ref076","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.08.012"},{"key":"10.23736\/S0026-4806.20.07019-6_ref077","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2017.7028"},{"key":"10.23736\/S0026-4806.20.07019-6_ref078","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.6499"},{"key":"10.23736\/S0026-4806.20.07019-6_ref079","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-009-0440-0"},{"key":"10.23736\/S0026-4806.20.07019-6_ref080","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405029"},{"key":"10.23736\/S0026-4806.20.07019-6_ref081","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.220.121"},{"key":"10.23736\/S0026-4806.20.07019-6_ref082","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0899"},{"key":"10.23736\/S0026-4806.20.07019-6_ref083","doi-asserted-by":"publisher","DOI":"10.1126\/science.3240341"},{"key":"10.23736\/S0026-4806.20.07019-6_ref084","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-7864(02)00235-5"},{"key":"10.23736\/S0026-4806.20.07019-6_ref085","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207196"},{"key":"10.23736\/S0026-4806.20.07019-6_ref086","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00127"},{"key":"10.23736\/S0026-4806.20.07019-6_ref087","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2014.02.020"},{"key":"10.23736\/S0026-4806.20.07019-6_ref088","first-page":"5487","article-title":"Gemtuzumab ozogamicin and olaparib exert synergistic cytotoxicity in CD33-positive HL-60 myeloid leukemia cells","volume":"34","author":"Yamauchi T","year":"2014","journal-title":"Anticancer Res"},{"key":"10.23736\/S0026-4806.20.07019-6_ref089","first-page":"68","article-title":"Gemtuzumab ozogamicin: back again","volume":"10","author":"Selby C","year":"2019","journal-title":"J Adv Pract Oncol"}],"container-title":["Minerva Medica"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R10Y2020N05A0395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T02:45:29Z","timestamp":1606790729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R10Y2020N05A0395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":89,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.23736\/s0026-4806.20.07019-6","relation":{},"ISSN":["0026-4806","1827-1669"],"issn-type":[{"value":"0026-4806","type":"print"},{"value":"1827-1669","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}